XT
SRNE

XTX Topco’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

XTX Topco’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-357,879
Closed -$317K – 1791
2022
Q4 		$317K Buy
+357,879
New +$475K 0.07% 549
2022
Q3 		– Sell
-97,095
Closed -$195K – 1486
2022
Q2 		$195K Buy
97,095
+77,843
+404% +$135K 0.08% 476
2022
Q1 		$45K Buy
19,252
+1,135
+6% +$3.54K 0.02% 601
2021
Q4 		$84K Buy
+18,117
New +$112K 0.05% 497

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

XTX Topco's SRNE Position: Q1 2023 in Review

XTX Topco sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 357,879 shares — an estimated $317K sold.

XTX Topco first reported a position in SRNE in Q4 2021 and held it in 4 quarters. The position peaked at $317K in Q4 2022. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • XTX Topco reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • XTX Topco sold 357,879 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $317K.
  • XTX Topco first reported a position in Sorrento Therapeutics, Inc. in Q4 2021 and held it in 4 quarters.
  • XTX Topco's Sorrento Therapeutics, Inc. position peaked at $317K in Q4 2022.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on XTX Topco's 13F filing for Q1 2023, filed 12 May 2023.